
MEDITATION PEACE OF SOUL
Share
1. INDICATIONS AND USE
Clinical meditation PEACE OF SOUL is indicated for:
NEUROLOGY
Complementary therapy for conditions and disorders affecting the autonomic nervous system:
- Type 2 diabetes
- Amyloidosis
- Autoimmune and inflammatory conditions (Guillain-Barré syndrome)
- Congenital and genetic conditions
- Infections (viruses such as HIV; bacteria from insect bites that cause Lyme disease or Chagas disease; botulism or tetanus)
- Multiple system atrophy
- Poisons and toxins (toxic heavy metals such as mercury, lead, industrial chemicals, alcohol)
- Trauma (especially spinal cord injuries that damage or interrupt autonomic connections below)
- Tumors (cancer and benign neoplasms)
RHEUMATOLOGY
Adjunctive therapy for amyloidosis:
- AL amyloidosis (immunoglobulin light chain amyloidosis)
- AA amyloidosis (formerly known as secondary amyloidosis)
- Dialysis-associated amyloidosis (DRA)
- Familial (or hereditary) Amyloidosis
- Wild-type amyloidosis (formerly senile systemic amyloidosis)
- Organ-specific amyloidosis
ONCOLOGY
Adjunctive therapy for sarcoma:
- soft tissues
- bones, or osteosarcoma
Additional therapy for blastoma:
- Hepatoblastomas
- Medulloblastomas
- Nephroblastomas
- Neuroblastomas
- Pleuropulmonary blastoma
HEMATOLOGY
Additional therapy for diseases of the hematopoietic system:
- Anemia
- Leukemia
- Thrombocytopenia
PSYCHIATRY
Complementary Therapy for Anxiety Disorders:
- Generalized anxiety disorder
- Panic disorder
- Phobia
- Specific phobias (agoraphobia, social anxiety disorder, separation anxiety disorder)
2. EXECUTION TIME
2.1 Recommended
During the daytime
In the evening
At night
2.2 Not recommended
In the morning
3. FREQUENCY OF USE
3.1 Use in patients aged 18 years and over
The minimum course of therapy is 2 weeks. It is recommended:
- 1 time in 2 days
- as needed
3.2 Use in the elderly
No adjustment of the frequency of administration is required in individuals over 65 years of age.
3.3 Administrative information
You can practice meditation while sitting or lying down in any comfortable position.
4. EFFECTIVENESS AND THERAPEUTIC EFFECT
4.1 Start of action
From 5 hours
4.2 Maximum effect
From 8 days
4.3 Decrease in action
From 14 days
4.4 Therapeutic effect
From 14 days
5. CONTRAINDICATIONS
5.1 Meditation is not recommended for use by patients
There are no contraindications
6. WARNINGS AND PRECAUTIONS
6.1 Impact on driving vehicles
May affect ability to drive for 30 minutes
6.2 Drowsiness/sedation
After practicing meditation, you may experience drowsiness or sedation for 30 minutes.
7. INTERACTIONS WITH OTHER PRACTICES OR DRUGS
There are no contraindications
8. USE IN SPECIFIC GROUPS
8.1 Pregnancy
No adjustment of frequency of use is required during pregnancy.
8.2 Lactation period
No adjustment of the frequency of administration is required during lactation.
8.3 Use in pediatrics
Not recommended for persons under 18 years of age
8.4 Geriatric use
No adjustment of the frequency of administration is required in individuals over 65 years of age.